midodrine has been researched along with Myoclonic Jerk in 1 studies
Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
Excerpt | Relevance | Reference |
---|---|---|
"Midodrine is widely used in the treatment of hypotensive states, there have been no reports of myoclonus associated with midodrine use in hypotension with chronic kidney disease." | 7.96 | Case report: severe myoclonus associated with oral midodrine treatment for hypotension. ( Chen, M; Ling, B; Ren, Y; Song, F; Wu, J; Wu, S; Xuan, Z; Ye, X; Zhang, H, 2020) |
"Midodrine is widely used in the treatment of hypotensive states, there have been no reports of myoclonus associated with midodrine use in hypotension with chronic kidney disease." | 3.96 | Case report: severe myoclonus associated with oral midodrine treatment for hypotension. ( Chen, M; Ling, B; Ren, Y; Song, F; Wu, J; Wu, S; Xuan, Z; Ye, X; Zhang, H, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ye, X | 1 |
Ling, B | 1 |
Wu, J | 1 |
Wu, S | 1 |
Ren, Y | 1 |
Zhang, H | 1 |
Song, F | 1 |
Xuan, Z | 1 |
Chen, M | 1 |
1 other study available for midodrine and Myoclonic Jerk
Article | Year |
---|---|
Case report: severe myoclonus associated with oral midodrine treatment for hypotension.
Topics: Administration, Oral; Adrenergic alpha-1 Receptor Agonists; Female; Humans; Hypotension; Middle Aged | 2020 |